Through the establishment of a U14 cervical cancer xenograft model and trying different doses of GaAD19 in combination with JNK agonists to treat nude mice, we observed that GaAD19 can inhibit tumor growth in these mice by inhibiting the JNK pathway. Here, MAPK8 is linked to cervical cancer.